Skip to main content
SpringerLink
Log in

Hemodynamic Support in PCI: From Chronic Heart Failure to Cardiogenic Shock

  • Chapter
  • First Online:
Textbook of Cardiovascular Intervention

  • 2616 Accesses

Abstract

Inotrope and vasopressor therapies have been demonstrated to adversely impact infarct size and survival in return for a modest increase in short-term survival. Earlier institution of mechanical support devices may allow the heart to rest while preserving systemic perfusion. Preliminary studies indicate that such a strategy would decrease final infarct size, particularly if implemented early, and should lower mortality rates.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics–2011 update: a report from the American Heart Association. Circulation. 2011;123(4):e18–209.

    Article  PubMed  Google Scholar 

  2. Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011;8(1):30–41.

    Article  PubMed  Google Scholar 

  3. Torabi A, Rigby AS, Cleland JG. Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. J Am Coll Cardiol. 2009;55(1):79–81; author reply 81.

    Article  PubMed  Google Scholar 

  4. Wu C, Hannan EL, Walford G, et al. A risk score to predict in-hospital mortality for percutaneous coronary interventions. J Am Coll Cardiol. 2006;47(3):654–60.

    Article  PubMed  Google Scholar 

  5. Singh M, Rihal CS, Selzer F, Kip KE, Detre K, Holmes DR. Validation of Mayo Clinic risk adjustment model for in-hospital complications after percutaneous coronary interventions, using the National Heart, Lung, and Blood Institute dynamic registry. J Am Coll Cardiol. 2003;42(10):1722–8.

    Article  PubMed  Google Scholar 

  6. Holper EM, Blair J, Selzer F, et al. The impact of ejection fraction on outcomes after percutaneous coronary intervention in patients with congestive heart failure: an analysis of the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry and Dynamic Registry. Am Heart J. Jan 2006;151(1):69–75.

    Article  PubMed  Google Scholar 

  7. Hochman JS. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation. 2003;107(24):2998–3002.

    Article  PubMed  Google Scholar 

  8. Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA. 2005;294(4):448–54.

    Article  PubMed  CAS  Google Scholar 

  9. Lowes BD, Minobe W, Abraham WT, et al. Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest. 1997;100(9):2315–24.

    Article  PubMed  CAS  Google Scholar 

  10. Meyer M, Schillinger W, Pieske B, et al. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation. 1995;92(4):778–84.

    Article  PubMed  CAS  Google Scholar 

  11. Liao R, Nascimben L, Friedrich J, Gwathmey JK, Ingwall JS. Decreased energy reserve in an animal model of dilated cardiomyopathy. Relationship to contractile performance. Circ Res. 1996;78(5):893–902.

    Article  PubMed  CAS  Google Scholar 

  12. Dibner-Dunlap ME, Thames MD. Control of sympathetic nerve activity by vagal mechanoreflexes is blunted in heart failure. Circulation. 1992;86(6):1929–34.

    Article  PubMed  CAS  Google Scholar 

  13. Vogel RA, Shawl F, Tommaso C, et al. Initial report of the National Registry of Elective Cardiopulmonary Bypass Supported Coronary Angioplasty. J Am Coll Cardiol. 1990;15(1):23–9.

    Article  PubMed  CAS  Google Scholar 

  14. Califf RM, Phillips 3rd HR, Hindman MC, et al. Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol. 1985;5(5):1055–63.

    Article  PubMed  CAS  Google Scholar 

  15. Fang J, Alderman MH, Keenan NL, Ayala C. Acute myocardial infarction hospitalization in the United States, 1979 to 2005. Am J Med. 2010;123(3):259–66.

    Article  PubMed  Google Scholar 

  16. Floyd KC, Yarzebski J, Spencer FA, et al. A 30-year perspective (1975–2005) into the changing landscape of patients hospitalized with initial acute myocardial infarction: Worcester Heart Attack Study. Circ Cardiovasc Qual Outcomes. 2009;2(2):88–95.

    Article  PubMed  Google Scholar 

  17. Cheng JM, Valk SD, den Uil CA, et al. Usefulness of intra-aortic balloon pump counterpulsation in patients with cardiogenic shock from acute myocardial infarction. Am J Cardiol. 2009;104(3):327–32.

    Article  PubMed  Google Scholar 

  18. Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med. 1999;340(15):1162–8.

    Article  PubMed  CAS  Google Scholar 

  19. Dunser MW, Hasibeder WR. Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med. 2009;24(5):293–316.

    Article  PubMed  Google Scholar 

  20. Petersen JW, Felker GM. Inotropes in the management of acute heart failure. Crit Care Med. 2008;36(1 Suppl):S106–11.

    Article  PubMed  CAS  Google Scholar 

  21. Fincke R, Hochman JS, Lowe AM, et al. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol. 2004;44(2):340–8.

    Article  PubMed  Google Scholar 

  22. Mendoza DD, Cooper HA, Panza JA. Cardiac power output predicts mortality across a broad spectrum of patients with acute cardiac disease. Am Heart J. 2007;153(3):366–70.

    Article  PubMed  Google Scholar 

  23. Kantrowitz A, Tjonneland S, Freed PS, Phillips SJ, Butner AN, Sherman Jr JL. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA. 1968;203(2):113–8.

    Article  PubMed  CAS  Google Scholar 

  24. Scheidt S, Wilner G, Mueller H, et al. Intra-aortic balloon counterpulsation in cardiogenic shock. Report of a co-operative clinical trial. N Engl J Med. 1973;288(19):979–84.

    Article  PubMed  CAS  Google Scholar 

  25. Kern MJ, Aguirre F, Bach R, Donohue T, Siegel R, Segal J. Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after coronary angioplasty. Circulation. 1993;87(2):500–11.

    Article  PubMed  CAS  Google Scholar 

  26. Weber KT, Janicki JS. Intraaortic balloon counterpulsation. A review of physiological principles, clinical results, and device safety. Ann Thorac Surg. 1974;17(6):602–36.

    Article  PubMed  CAS  Google Scholar 

  27. Cohen M, Urban P, Christenson JT, et al. Intra-aortic balloon counterpulsation in US and non-US centres: results of the Benchmark Registry. Eur Heart J. 2003;24(19):1763–70.

    Article  PubMed  Google Scholar 

  28. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation. 2004;110(9):e82–292.

    PubMed  Google Scholar 

  29. Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2008;29(23):2909–45.

    Article  PubMed  Google Scholar 

  30. Barron HV, Every NR, Parsons LS, et al. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J. 2001;141(6):933–9.

    Article  PubMed  CAS  Google Scholar 

  31. Sanborn TA, Sleeper LA, Bates ER, et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol. 2000;36(3 Suppl A):1123–9.

    Article  PubMed  CAS  Google Scholar 

  32. Sjauw KD, Engstrom AE, Vis MM, et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J. 2009;30(4):459–68.

    Article  PubMed  Google Scholar 

  33. Ferguson 3rd JJ, Cohen M, Freedman Jr RJ, et al. The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry. J Am Coll Cardiol. 2001;38(5):1456–62.

    Article  PubMed  Google Scholar 

  34. Patel MR, Thiele H, Smalling RW, et al. A multicenter, randomized, controlled study of mechanical left ventricular unloading with counterpulsation to reduce infarct size prepercutaneous coronary intervention for acute myocardial infarction: rationale and design of the Counterpulsation Reduces Infarct Size Acute Myocardial Infarction trial. Am Heart J. 2011;162(1):47–55 e41.

    Article  PubMed  Google Scholar 

  35. Thiele H, Zeymer U, Nuemann FJ, Ferenc M, Olbrich HG, Hausleiter J, Richardt G, Hennersdorf HG, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Fuhrmann J, Bohm M, Ebeit H, Schneider S, Schuler G, Werdan K. Intraaortic balloon support for cardiogenic shock. N Engl J Med. 2012;367:1287–96.

    Article  PubMed  CAS  Google Scholar 

  36. Thiele H, Lauer B, Hambrecht R, Boudriot E, Cohen HA, Schuler G. Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation. 2001;104(24):2917–22.

    Article  PubMed  CAS  Google Scholar 

  37. Henriques JP, Remmelink M, Baan Jr J, et al. Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5. Am J Cardiol. 2006;97(7):990–2.

    Article  PubMed  Google Scholar 

  38. Cheng JM, den Uil CA, Hoeks SE, et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J. 2009;30(17):2102–8.

    Article  PubMed  Google Scholar 

  39. Thiele H, Sick P, Boudriot E, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005;26(13):1276–83.

    Article  PubMed  Google Scholar 

  40. Al-Husami W, Yturralde F, Mohanty G, et al. Single-center experience with the TandemHeart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention. J Invasive Cardiol. 2008;20(6):319–22.

    PubMed  Google Scholar 

  41. Morley D, Litwak K, Ferber P, et al. Hemodynamic effects of partial ventricular support in chronic heart failure: results of simulation validated with in vivo data. J Thorac Cardiovasc Surg. 2007;133(1):21–8.

    Article  PubMed  Google Scholar 

  42. Fonger JD, Zhou Y, Matsuura H, Aldea GS, Shemin RJ. Enhanced preservation of acutely ischemic myocardium with transseptal left ventricular assist. Ann Thorac Surg. 1994;57(3):570–5.

    Article  PubMed  CAS  Google Scholar 

  43. Sjauw KD, Remmelink M, Baan Jr J, et al. Left ventricular unloading in acute ST-segment elevation myocardial infarction patients is safe and feasible and provides acute and sustained left ventricular recovery. J Am Coll Cardiol. 2008;51(10):1044–6.

    Article  PubMed  Google Scholar 

  44. Dixon SR, Henriques JP, Mauri L, et al. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. JACC Cardiovasc Interv. 2009;2(2):91–6.

    Article  PubMed  Google Scholar 

  45. Seyfarth M, Sibbing D, Bauer I, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52(19):1584–8.

    Article  PubMed  Google Scholar 

  46. O’Neill WW, Kleiman NS, Moses J, Henriques JP, Dixon S, Massaro J, Palacios I, Maini B, Mulukutla S, Dzavik V, Popma J, Douglas PS, Ohman M. A prospective, randomized clinical trial of hemodynamic support with impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the protect ii study. Circulation. 2012;126:1717–27.

    Article  PubMed  Google Scholar 

  47. Sjauw KD, Konorza T, Erbel R, et al. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry. J Am Coll Cardiol. 2009;54(25):2430–4.

    Article  PubMed  Google Scholar 

  48. Cyrus T, et al. Use of mechanical assist during high-risk PCI and STEMI with cardiogenic shock. Cathet Cardiovasc Interv. 2010;75:S1–6.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Interventional Cardiology, Lenox Hill Hospital, 100 E 77th St., New York, NY, 10021, USA

    Jooby John MD, MPH & Kirk N. Garratt MSc, MD

Authors
  1. Jooby John MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kirk N. Garratt MSc, MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jooby John MD, MPH .

Editor information

Editors and Affiliations

  1. Department of Medicine, Cardiology Section, Director, Cardiovascular Catheterization and Intervention, Yale New Haven Hospital, Director, Invasive Cardiology and Vascular Medicine,, New Haven, Connecticut, USA

    Craig A. Thompson

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

John, J., Garratt, K.N. (2014). Hemodynamic Support in PCI: From Chronic Heart Failure to Cardiogenic Shock . In: Thompson, C. (eds) Textbook of Cardiovascular Intervention. Springer, London. https://doi.org/10.1007/978-1-4471-4528-8_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4528-8_17

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4527-1

  • Online ISBN: 978-1-4471-4528-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation